R.I. Nicholson - Concepedia

Author

R.I. Nicholson

Also Known As

Nicholson, R.I., R I Nicholson, R Nicholson, R. I. NICHOLSON, R. I. Nicholson, R. Nicholson, R.I Nicholson, R.I. Nicholson, RI Nicholson, Rachael Nicholson

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Tenovus Cancer Care Nottingham City Hospital Cardiff University University of Wales AstraZeneca (United Kingdom)

About

R.I. Nicholson is an author at Tenovus Cancer Care specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	1.2K
2	Endocrinology	7	7	577
3	Cell Biology	5	5	217
4	Health Sciences	3	3	60
5	Public Health	1	1	53

R.I. Nicholson

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Comparison of the Effects of a Pure Steroidal antiestrogen With Those of Tamoxifen in a Model of Human Breast Cancer C. Kent Osborne, Ester Coronado-Heinsohn, S. G. Hilsenbeck, JNCI Journal of the National Cancer Institute	1995	362
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. D.J. DeFriend, Anthony Howell, R.I. Nicholson, PubMed Breast OncologyOncologyMedicineHormonal ReceptorGynecology	1994	291
Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast Kurt Werner Schmid, Ian O. Ellis, Julia M.W. Gee, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin Demonstrable Metallothionein Over-expressionBreast OncologyMedicineMammary GlandPathology	1993	122
Invasive lobular carcinomas of the breast – the prognosis of histopathological subtypes R S Du Toit, A P Locker, C.W. Elston, British Journal of Cancer Tumoral PathologyBreast OncologyMedicineSurgical PathologyHistopathological Subtypes	1989	108
An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. R S Du Toit, A P Locker, Ian O. Ellis, PubMed	1991	105
An immunohistochemical examination of the expression of E-cadherin, ?- and ?/?-catenins, and ?2- and ?1-integrins in invasive breast cancer Michael Gonzalez, Sarah E. Pinder, P.M. Wencyk, The Journal of Pathology	1999	99
Oestrogen-regulated genes in breast cancer: Association of pLIV1 with lymph node involvement David L. Manning, John F. R. Robertson, Ian O. Ellis, European Journal of Cancer Breast OncologyOestrogen-regulated GenesMedicineLymph Node InvolvementBreast Cancer	1994	94
DETERMINATION OF TAMOXIFEN AND AN HYDROXYLATED METABOLITE IN PLASMA FROM PATIENTS WITH ADVANCED BREAST CANCER USING GAS CHROMATOGRAPHY–MASS SPECTROMETRY C. Paul Daniel, Simon J. Gaskell, H. H. Bishop, Journal of Endocrinology Breast OncologyMetabolomic ProfilingGynecologyPharmacotherapyOvarian Cancer	1979	78
Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells Stephen Hiscox, Nicola Jordan, Christopher G. Smith, Breast Cancer Research and Treatment Tumor BiologyBreast OncologyAntihormone ResistanceMedicineBreast Cancer Cells	2008	74
A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification R A McClelland, D W Wilson, Robin Leake, European Journal of Cancer and Clinical Oncology MedicineHormonal ReceptorMulticentre StudyImmunologyClinical Chemistry	1991	64

Page 1